“Successful Use of the Intensity IOL: Best Practices for Optimal Patient Outcomes” by Prof. Manfred Tetz

In this MedTalk from ESCRS 2025, Prof. Jorge L. Alió shares results from a prospective study conducted with 64 eyes that underwent bilateral cataract surgery with the Intensity® Pentafocal IOL. He reports that the 5-foci distribution principle of the lens, meant to provide continuous vision across all distances, is confirmed by the flat defocus curve. Side effects typical of multifocal optics were minimal, supporting smooth adaptation for patients with high

In this MedTalk from ESCRS 2025, Dr. Germán Bianchi reports early clinical experience with the Extend™ monofocal plus IOL in bilateral cataract surgery. Across the first 12 patients followed to three months, distance vision improved in every case, and intermediate performance was consistently strong. For most patients, “near vision efficacy was also good.” Learn more here.

In this ESCRS 2025 MedTalk, Dr. Pavel Stodůlka presents early clinical outcomes with Hanita Lenses’ Extend™ monofocal plus IOL. The lens features a hydrophobic, glistening-free material and a Bessel-beam optical concept designed to gently broaden depth of focus. Based on the initial series of 29 patients implanted with Extend™ SL or Extend™ Toric, he reports strong refractive accuracy along with dependable intermediate visual performance. Learn more here.

In this MedTalk from ESCRS 2025, Dr. Sabrina Vismara shares clinical performance insights on the Extend™, the world’s first Bessel optics monofocal plus IOL. Supporting data from multiple surgeons demonstrate functional intermediate vision; and visual disturbances and far VA comparable to standard monofocals. Learn more here.